Common side effects The most frequent complaints involve local skin reactions
A 20% reduction in heart attacks, strokes, and cardiovascular death prevents far more serious harm than the potential increase in treatable DVT events
In a 26-week Phase 2 obesity trial, cagrilintide 4.5mg produced a mean body-weight reduction of 10.8%, versus 3.0% on placebo and it outperformed liraglutide 3.0mg (10.8% vs 9.0%)[1]
Their passion for medical excellence is reflected in every procedure they perform and in the compassionate support they provide to our patients at all times
This review summarizes various immune mechanisms and therapeutic targets associated with these two types of fatty liver disease
Create a Support System Weight loss journeys are more successful with support, whether its from friends, family, or healthcare professionals